ROIV - Roivant Sciences Ltd.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$37.17
DETAILS
HIGH:
$42.00
LOW:
$30.00
MEDIAN:
$38.00
CONSENSUS:
$37.17
UPSIDE:
6.47%
Profitability Ratios
| Ratio | Value |
|---|---|
| GP Margin | 84.4% |
| EBIT Margin | -3203.1% |
| EBITDA Margin | -3162.6% |
| Operating Margin | -15560.6% |
| Pretax Margin | -3203.1% |
| Cont. Ops Margin | -4817.3% |
| Net Margin | -3629.2% |
| Bottom Line Margin | -3629.2% |
Liquidity Ratios
| Ratio | Value |
|---|---|
| Current Ratio | 18.37 |
| Quick Ratio | 18.37 |
| Solvency Ratio | -0.680 |
| Cash Ratio | 5.06 |
Valuation Ratios
| Ratio | Value |
|---|---|
| Price/Earnings | |
| PEG Ratio | -0.81 |
| Forward PEG | -0.81 |
| Price/Book | 4.25 |
| Price/Sales | 2326.88 |
| Price/FCF | -25.34 |
| Price/Op Cash Flow | -25.61 |
Debt Ratios
| Ratio | Value |
|---|---|
| Debt/Assets | 0.0188 |
| Debt/Equity | 0.0237 |
| Debt/Capital | 0.0232 |
| Long-Term Debt/Capital | 0.0000 |
| Financial Leverage | 1.27 |
Cash Flow Ratios
| Ratio | Value |
|---|---|
| Working Capital Turnover | 0.00 |
| Operating Cash Flow Ratio | -2.668 |
| Operating Cash Flow/Sales | -9084.1% |
| Free Cash Flow/Operating Cash Flow | 101.1% |
Coverage Ratios
| Ratio | Value |
|---|---|
| Debt Service Coverage | -35.40 |
| Interest Coverage | 0.0000 |
| Short-Term Operating Cash Flow Coverage | -67.31 |
| Operating Cash Flow Coverage | -6.98 |
| Capital Expenditure Coverage | -91.41 |
| Dividend + Capital Expenditure Coverage | -91.41 |
Dividend Ratios
| Ratio | Value |
|---|---|
| Payout Ratio | 0.0000% |
| Dividend Yield | 0.0000% |
| Dividend Yield % | 0.0000% |
| Dividend Per Share | 0.0000 |
Per Share Ratios
| Ratio | Value |
|---|---|
| Revenue/Share | 0.01 |
| EPS | -0.432 |
| Debt/Share | 0.1548 |
| Cash/Share | 6.19 |
| Book Value/Share | 7.63 |
| Tangible BV/Share | 7.63 |
| Equity/Share | 6.52 |
| Operating Cash Flow/Share | -1.081 |
| Capital Expenditure/Share | 0.012 |
| FCF/Share | -1.093 |
Other Ratios
| Ratio | Value |
|---|---|
| Net Income/Earnings Before Tax | 1.133 |
| Earnings Before Tax/EBIT | 0.206 |
| Price/Fair Value | 4.25 |
| Debt/Market Cap | 0.0006 |
| Effective Tax Rate | -50.4% |
| Enterprise Value Multiple | -68.54 |